Method of treating lymphedema comprising administering VEGF-D
US7829536B2 · kind B2 · utility
2Cited by
37References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 5, 2009 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Feb 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.